Yingfei Fan "Settled" in Xinhua Pharmacy
Release time:
2020-07-15
The number of designated charity drug donation varieties in Jinqu region has reached 16
. Recently, the first PD-L1 immunotherapy drug duvalizumab (Yingfeifan) approved for listing in China has officially started to be sold. Xinhua Pharmacy, the peak pharmacy, has become the only designated pharmacy in Yingfeifan in Jinqu region and is also the designated service point for charity drug donation in Yingfeifan. On March 27, Xinhua Pharmacy completed the first sale of Yingfeifan, which was delivered to patients by licensed pharmacists in the pharmacy.
Infeifan was formally approved by the National Drug Administration (NMPA) in December 2019 for the treatment of patients with unresectable, stage III non-small cell lung cancer (NSCLC) who have not progressed after receiving platinum-based chemotherapy and concurrent radiotherapy. The results of phase III PACIFIC clinical trials show that the use of Imfinzi immunotherapy after concurrent radiotherapy and chemotherapy reduces the risk of death by nearly 32% in patients with stage III inoperable NSCLC. The median progression-free survival (PFS) is 16.8 months, and the 3-year overall survival rate (OS) is as high as 57%. Infineon is the first PD-L1 immunosuppressant approved for the treatment of stage III lung cancer in mainland China. The approval marks a new era of immunotherapy for unresectable stage III non-small cell lung cancer in China.
In order to improve the accessibility and standardization of lung cancer immunotherapy for lung cancer patients, reduce the economic burden of patients and prolong the life of patients. The China Primary Health Care Foundation officially launched the "Aifan-Lung Cancer Immunotherapy Patient Assistance Project" on February 29. Patients with low-income insurance who meet the indications for the treatment of duvalizumab can receive free charity drugs until the disease progresses. In the first round, patients can get 2 courses of drug assistance free of charge after using 2 courses of duvalizumab at their own expense; in the second round, patients can get 4 courses of drug assistance free of charge after using 4 courses of duvalizumab at their own expense; in the third round, patients can get 8 courses of free drug assistance after using 6 courses of duvalizumab at their own expense, under the premise that the disease does not progress, the subsequent application for drug donation can be circulated. After investigation and evaluation in various aspects, Xinhua Pharmacy has become a designated service point for charity drug donation in Yingfeifan in Jinliqu area.
Xinhua Pharmacy is a designated pharmacy for serious illness medical insurance in Jinhua City, with complete drug equipment. All hardware facilities are perfect. For drugs that need to be refrigerated, pharmacies have special refrigerators for storage. The refrigerators are equipped with monitoring probes, which are connected to the mobile phone system. If the temperature is abnormal, SMS alarm will be issued. At the same time, Xinhua Pharmacy is also equipped with special personnel to provide drug donation services, which have previously been identified as designated service points for charity drug donation of many varieties such as Terrisa, Iressa, Gnico, Herceptin and Libitai. After Yingfeifan "settled down", there are 16 varieties of designated charity drugs in Jinqu area of Xinhua drugstore. (Reporter Ni Yingzhen)
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page